Bioxytran, Inc. BIXT
0.02 USD 0.00 (-2.76%)
At closeNov 3, 2026, 4:00 PM EST
0.0205 Day range 0.0206
0.02 52-week range 0.0949
- YTD
- -72.16%
- 1 year
- -69.11%
- Market cap
- 2.42M
- EPS (ttm)
- -0.02
- YTD return
- -72.16%
- 1-year return
- -69.11%
- Volume
- 30.00K
- Avg volume
- 92.04K
- Open
- 0.0206
- Previous close
- 0.0217
- Day's range
- 0.0205 – 0.0206
- 52-week range
- 0.02 – 0.0949
- Earnings date
- Nov 2, 2023
2Y -0.0705 (-77.46%)
Next earnings
Nov 2, 2023
Expected Nov 2, 2023. Consensus EPS estimate 0.00.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Oct 28, 2024 | Sep 1, 2024 | 0.00 | 0.00 | — | — |
| Aug 14, 2024 | Jun 1, 2024 | 0.00 | 0.00 | — | — |
| Apr 19, 2024 | Mar 1, 2024 | 0.00 | 0.00 | — | — |
| Mar 22, 2024 | Dec 1, 2023 | 0.00 | -0.01 | — | — |
| Nov 2, 2023 | Sep 1, 2023 | 0.00 | — | — | — |
| Jul 31, 2023 | Jun 1, 2023 | 0.00 | -0.01 | — | — |
News
Bioxytran Secures Attested Free Sale Certification for A-SUQAR®, Opening the Path to the UAE and Gulf Markets 
Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar 
Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs 
Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research 
Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25 
Bioxytran, Inc. (OTCMKTS:BIXT) Sees Significant Decline in Short Interest 
BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT 
Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M 
Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19 
Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran
Your note
Sign in to keep a note on BIXT — it syncs with the Stock Master app.